CST3 and chronic kidney disease: Future studies could utilise Cystatin C measurement as a biomarker for kidney function as it is not associated with muscle mass, to greater reflect kidney function in these patient groups.41 Alternatively, proteinuria could be used as a marker of kidney damage and predictor of CKD progression.